Signaturefd, LLC
- SEC CIK
- 0001456048
- Latest filing
- Jul 23, 2026
KROS holding history
Keros Therapeutics, Inc. in every 13F filed by Signaturefd, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KROS overviewAll 13F holders of KROSFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −1,280−100.0% | Sold out | Holders |
| Q1 2026 | 1,280 | $14.1K | <0.1% | −682−34.8% | Reduced | Holders |
| Q4 2025 | 1,962 | $39.9K | <0.1% | +311+18.8% | Added | Holders |
| Q3 2025 | 1,651 | $26.1K | <0.1% | +354+27.3% | Added | Holders |
| Q2 2025 | 1,297 | $17.3K | <0.1% | +300+30.1% | Added | Holders |
| Q1 2025 | 997 | $10.2K | <0.1% | +921+1,211.8% | Added | Holders |
| Q4 2024 | 76 | $1.20K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 76 | $4.41K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 76 | $3.47K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 76 | $5.03K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 76 | $3.02K | <0.1% | +76 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −10−100.0% | Sold out | Holders |
| Q1 2023 | 10 | $427 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 10 | $480 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10 | $0 | 0.0% | +10 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −13−100.0% | Sold out | Holders |
| Q1 2022 | 13 | $1.00K | <0.1% | +13 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −18−100.0% | Sold out | Holders |
| Q2 2021 | 18 | $1.00K | <0.1% | +18 | New | Holders |